Cabaletta Bio (CABA) Change in Accured Expenses (2018 - 2025)

Cabaletta Bio's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at $3.1 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses rose 167.53% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $7.4 million (changed N/A YoY), while the FY2025 annual figure was $7.4 million, changed N/A from the prior year.
• Change in Accured Expenses for Q4 2025 stood at $3.1 million, up from $2.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $6.4 million in Q3 2024, with the low at -$4.5 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is $798500.0 (2023), against an average of $566850.0.
• Peak annual rise in Change in Accured Expenses reached 878.15% in 2024, while the deepest fall reached 247.7% in 2024.
• Cabaletta Bio's Change in Accured Expenses stood at $1.7 million in 2021, then plunged by 77.18% to $395000.0 in 2022, then surged by 674.94% to $3.1 million in 2023, then plunged by 247.7% to -$4.5 million in 2024, then surged by 167.53% to $3.1 million in 2025.
• Business Quant data shows CABA's Change in Accured Expenses at $3.1 million in Q4 2025, $2.3 million in Q3 2025, and $5.6 million in Q2 2025.